Esofagitis Refluks Pada Anak

Badriul Hegar, R. Lia Mulyani

Sari


Esofagitis refluks adalah proses inflamasi pada esofagus akibat refluks gastroesofagus.
Toksisitas isi refluks, frekuensi, durasi episode refluks, dan resistensi esofagus terhadap
isi refluks merupakan faktor yang berperan terhadap kejadian esofagitis. Gejala klinis
esofagitis refluks tidak spesifik. Pada bayi sering terlihat muntah disertai gejala klinis
iritabel, tidur tidak nyaman, menolak makan, dan gagal tumbuh, sedangkan pada anak
yang lebih besar didapatkan keluhan heartburn dan nyeri epigastrium. Esofagitis tersebar
secara ‘patchy’ dan tidak merata sehingga ketelitian pemeriksaan sangat diperlukan.
Secara makroskopis mukosa esofagus dapat terlihat hiperemis, erosi, atau ulkus, sedangkan
pada patologi anatomi terlihat gambaran hiperplasia membran basal dengan papila yang
memanjang. Antagonis reseptor H2 dan inhibitor pompa proton (IPP) telah digunakan
secara luas untuk terapi esofagitis. Efek jangka pendek, jangka panjang, dan pencegahan
relaps obat-obat tersebut memperlihatkan hasil yang memuaskan, walaupun beberapa
data menunjukkan keunggulan IPP dibanding antagonis reseptor H2.


Kata Kunci


refluks gastroesofagus; esofagitis; antagonis reseptor H2; inhibitor pompa propton

Teks Lengkap:

PDF

Referensi


Chu AS. Esophagitis. Diunduh dari www.emedicine.

com, diakses tanggal 9 September 2004.

Orlando RC. Reflux esophagitis. Dalam: Yamada T,

penyunting. Textbook of gastroenterology. Edisi ke-2.

Philadelphia: Lippincott Company; 1995. h. 1214-41.

Vanderplas Y, Hegar B. Esophagitis ini children. Dalam:

Trihono PP, Pudjiarto PS, Syarif DR, Hegar B, Gunardi

H, Oswari H, dkk, penyunting. Hot topics in pediatrics

II. Jakarta: Balai Penerbit FKUI;2002. h. 74-83.

Hegar B, Rastra. Pendekatan tata laksana refluks

gastroesofagus pada anak. Maj Kedokt Indon 2004; 54:

-31.

Vandenplas Y, Hegar B. Diagnosis and treatment of

gastro-oesophageal reflux disease in infants and children.

J Gastroenterol Hepatol 2000;15:593-603.

Gold BD. Gastroesophageal reflux disease: could intervention

in childhood reduce the risk of later complications?

Am J Med 2004;117:23S-7S.7. Hegar B, Boediarso A, Firmansyah A, Vandenplas Y. Investigation

of regurgitation and other symptoms of gastroesophageal

reflux in Indonesian infans. World J

Gastroenterol 2004;10:1795-7.

Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence

of symptoms of gastroesophageal reflux during infancy.

Arc Pediatr Adolesc Med 1997;151:569-72.

Nelson SP, Chen EH, Syniar GM, Christoffel KK. Oneyear

follow-up of symptoms of gastroesophageal reflux

during infancy. Pediatrics 1998;102:1-4.

Salvatore S, Vandenplas Y. Gastro-oesophageal reflux disease

and motility disorders. Best Practice&Research Clin

Gastroenterol 2003;17:163-79.

El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic

manifestations of gastroesophageal reflux disease

in patiens between 18 months and 25 years without neurological

deficits. Am J Gastroenterol 2002;97:1635-9.

Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence

of symptoms of gastroesophageal reflux during

childhood. Arc Pediatr Adolesc Med 2000;154:150-4.

Hamilton SR. Reflux esophagitis and barrett esofagus.

Dalam: Goldman H, Appelman HD, Kaufman N,

penyunting. Gastrointestinal pathology. Baltimore: Williams

& Wilkins;1990. h. 11-29.

Hogan WJ, Dodds WJ. Gastroesophageal reflux disease

(reflux esophagitis). Dalam: Wickland E, penyunting.

Gastrointestinal disease. Edisi ke-4. Philadelphia: WB

Saunders;1989. h. 594-616.

Mittal RK. Pathophysiology of gastroesophageal reflux:

motility factors. J Gastroenterol 2003;38:7-12.

Davidson GP, Omari TI. Pathophysiological mechanisms

of gastroesophageal reflux disease in children. Gastroenterology

;3:257-62.

Spechler SJ. Gastroesophageal reflux disease and its complications.

Dalam: Grendell JH, McQuaid KR, Friedman

SL, penyunting. Current diagnosis and treatment

in gastroenterology. USA: Appleton and Lange; 1996.

h. 245-60.

Yoshida N, Yoshikawa T. Defense mechanism of the

esophageal mucosa and esophageal inflammation. J

Gastroenterol 2003;38:31-4.

Orel R, Marcovic S. Bile in the esophagus: a factor in

the pathogenesis of reflux esophagitis in children. J Ped

Gastroenterol Nutr 2003;36:172-4.

Hegar B, Firmansyah A. Diagnosis refluks gastroesofagus

pada anak. Maj Kedokt Indon 1999;49:70-4.

Aw M. Pediatric gastro-oesophageal reflux disease

(GERD). A relook at a common problem. National

university hospital. MITA 2003;34:1-14.

Sunku B, Marino RV, Sockolow R. A primary care approach

to pediatric gastroesophageal reflux. JOAO

;100:S11-S15.

Rudolph CD, Mazur LJ, Liptak GS, Baker RD, Boyle

JT, Colletti RB, dkk. Guidelines for evaluation and treatment

of gastroesophageal reflux in infants and children:

Recommendations for the north american society for

pediatric gastroenterologi and nutrition. J Pediatr

Gastroentrol Nutr 2001;32:S1-S31.

DeVault KR, Castell DO. Update guidelines for diagnosis

and treatment of gastroesophageal reflux disease.

Am j Gastroenterol 1999; 94:1434-42.

Hegar B, Vandenplas Y. Gastro-oesophageal reflux ini

infancy. J Gastroenterol Hepatol 1999;14:13-9.

Vieira MC, Pisani JC, Mulinari RA. Diagnosis of reflux

esophagitis in infants: histology of the distal esophagus

must complement upper gastrointestinal endoscopy. J

de Pediatria 2004; 80:197-202.

Vandenplas Y. Reflux esophagitis in infants and children:

a report from the Working Group on Gastroesophageal

Reflux Disease of the European Society of

Paediatric Gastroenterology and Nutrition. J Pediatr

Gastroenterol Nutr 1994;18:413-22.

Bronner MP. Inflammatory disorders of the esophagus.

Didapat dari www.google.com. Diakses tanggal 9

Desember 2004.

Esposito S, Valente G, Zavallone A, Guidali P, Rapa A,

Oderda G. Histological score for cells with irregular

nuclear contour for the diagnosis of reflux esophagitis

in children. Human Pathology 2004;35:96-100.

Cohen RC, O’Loughlin EV, Davidson GP, Moore DJ,

Lawrence DM. Cisapride in the control of symptoms in

infants with gastroesophageal reflux: a randomized, doubleblind,

placebo-controlled trial. J Pediatr 1999;134:287-92.

Vigneri S, Termini R, Leandro G, Badalamenti S,

Pantalena M, Savarino V, dkk. A comparison of five

maintenance therapies for reflux esophagitis. N Engl J

Med 1995;333:1106-10.

Zimmermann AE, Walters JK, Katona BG, Souney PF,

Levine D. A review of omeprazole use in the treatment

of acid-related disorders in children. Clin Ther 2001;

:660-79.

Israel DM, Hassall E. Omeprazol and other proton

inhibitors:pharmacology, efficacy and safety, with special

reference to use in children. J Pediatr Gastroenterol

Nutr 1998;27:568-79.

Karjoo M, Kane R. Omeprazol treatment of children

with peptic esophagitis refractory to ranitidine therapy.

Arch Pediatr Adolesc Med 1995;149:267-71.35. Madrazo-de la Garza A, Dibildox M, Vargas A, Delgado

J, Gonzalez J, Yanez P. Efficacy and safety of oral

pantoprazol 20 mg given once daily for reflux esophagitis

in children. J Pediatr Gastroenterol Nutr 2003;36:

-5.

Christensen ML, Gold BD. Clinical management of infant

and children with gastroesophageal reflux disease :

disease recognition and therapeutic options. ASHP Midyear

Clinical Meeting: 9 Desember 2002; Atlanta, Georgia;

h. 1-11.




DOI: http://dx.doi.org/10.14238/sp8.1.2006.43-53

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc-sa4.footer##

Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at] saripediatri.org

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.